跳至主要内容
临床试验/ACTRN12607000575437
ACTRN12607000575437尚未招募未知

In patients with wet Age Related Macular Degeneration, is ranibizumab intravitreal injection effective in improving visual acuity in the fellow eye?

Monash University0 个研究点目标入组 25 人开始时间: 2007年11月9日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • ARMD with choroidal neovascularisation in both eyes
  • Involvement of the foveal centre
  • Age 50 years or more
  • Visual Acuity (best corrected) of 6/12 or worse in both eyes (equivalent to >0.3 logMAR)

排除标准

  • Lesion size greater than 12 optic disc areas
  • Previous anti Vascular Endothelial Growth Factor (anti-VEGF) therapy
  • Contraindication for ranibizumab treatment
  • oHypersensitivity to ranibizumab
  • oActive or suspected ocular/periocular infection
  • oActive intraocular inflammation

研究者

相似试验

Fellow Eye Effect with Ranibizumab for Age Related... | 临床试验